KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Short-term Investments (2019 - 2020)

Boston Scientific's Short-term Investments history spans 8 years, with the latest figure at $97.0 million for Q3 2025.

  • For Q3 2025, Short-term Investments rose 385.0% year-over-year to $97.0 million; the TTM value through Sep 2025 reached $97.0 million, up 385.0%, while the annual FY2024 figure was $305.0 million, 185.05% up from the prior year.
  • Short-term Investments for Q3 2025 was $97.0 million at Boston Scientific, up from $89.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $367.0 million in Q3 2022 and bottomed at $20.0 million in Q3 2024.
  • The 5-year median for Short-term Investments is $155.0 million (2022), against an average of $171.4 million.
  • The largest annual shift saw Short-term Investments fell 28.19% in 2023 before it soared 385.0% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $169.0 million in 2021, then dropped by 11.83% to $149.0 million in 2022, then dropped by 28.19% to $107.0 million in 2023, then surged by 185.05% to $305.0 million in 2024, then plummeted by 68.2% to $97.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Short-term Investments are $97.0 million (Q3 2025), $89.0 million (Q2 2025), and $221.0 million (Q1 2025).